Research Progress on Low-Temperature Plasma Nucleoplasty and Targeted Radiofrequency for Cervical Spondylotic Radiculopathy: A Retrospective Review Authors: Jiajia Deng, Chenxuan Xiao, Keyue Xie Published: 2026 ABSTRACT AbstractCervical spondylotic radiculopathy (CSR) is a common neurological condition caused by compression or inflammation of cervical nerve roots, often resulting in significant pain and functional impairment. While many patients improve with conservative management, a substantial subset remains refractory and requires further intervention. Over the past 2 decades, minimally invasive percutaneous techniques have emerged as effective alternatives to conventional open surgery. This review synthesizes contemporary evidence on two key modalities: percutaneous cervical nucleoplasty (PCN), a decompressive procedure utilizing low-temperature plasma (coblation) technology to reduce intradiscal pressure, and pulsed radiofrequency (PRF) applied to the dorsal root ganglion, a neuromodulatory approach that modulates pain signaling without tissue destruction. Drawing on observational studies, randomized controlled trials, and systematic reviews, the article evaluates the clinical efficacy, safety, and durability of each technique, compares their outcomes with anterior cervical discectomy and fusion, and explores emerging combination strategies. Evidence indicates that both PCN and PRF provide significant and sustained pain relief with favorable safety profiles. PCN achieves long-term outcomes comparable to surgery in carefully selected patients with contained disc herniations, while PRF offers superior duration of relief compared with steroid injections alone. Emerging data support the synergistic use of PCN and PRF, as well as augmentation with intradiscal collagenase or ozone. Patient selection—guided by symptom duration, imaging characteristics, and predictive factors—remains critical for optimizing outcomes. Despite encouraging results, the evidence base is limited by study heterogeneity and moderate-to-low certainty. Future large-scale, multicenter randomized trials are needed to refine patient selection, optimize technical parameters, and establish comparative effectiveness. Overall, PCN and PRF represent valuable, minimally invasive options within a stepped-care approach to CSR, bridging conservative management and open surgery.Keywords: Cervical spondylotic radiculopathy, Percutaneous cervical nucleoplasty, Pulsed radiofrequency, Dorsal root ganglion, Minimally invasive spine surgery Key Summary Points Cervical spondylotic radiculopathy often improves with conservative care, but 26–35% of patients develop persistent symptoms requiring further intervention; minimally invasive techniques such as percutaneous cervical nucleoplasty and pulsed radiofrequency provide effective alternatives before considering open surgery.Percutaneous cervical nucleoplasty (PCN) uses low-temperature plasma (coblation) to ablate nucleus pulposus tissue, reducing intradiscal pressure and mechanical nerve root compression; it is most effective for contained, soft disc herniations with an intact annulus.Pulsed radiofrequency (PRF) applied to the cervical dorsal root ganglion exerts neuromodulatory effects—including suppression of pro-inflammatory cytokines and synaptic plasticity changes—without thermal nerve destruction, offering sustained pain relief superior to steroid injections alone in chronic radiculopathy.Direct comparisons show that PCN and PRF yield comparable clinical outcomes; the choice between them should be guided by the predominant pathophysiology (mechanical compression vs. neuroinflammatory irritation), and emerging evidence supports combining both modalities to address multifactorial pain mechanisms.Both PCN and PRF have favorable safety profiles with low complication rates; appropriate patient selection—based on symptom duration, absence of severe spinal stenosis, and predictive factors such as preoperative pain intensity—is essential to optimize outcomes and minimize recurrence. Introduction Cervical spondylotic radiculopathy (CSR) represents a prevalent and often debilitating neurological disorder characterized by pain, sensory disturbances, and sometimes motor weakness radiating into the upper extremity, resulting from compression and/or inflammatory irritation of cervical nerve roots. The primary pathological substrate is most frequently a herniated intervertebral disc, with degenerative changes contributing to foraminal narrowing. While cervical spondylotic radiculopathy (CSR) encompasses both radiculopathy caused by soft disc herniation and that resulting from bony foraminal stenosis, the present review focuses primarily on the former—contained soft disc herniations—for which percutaneous nucleoplasty (PCN) and pulsed radiofrequency (PRF) are most commonly indicated. The distinction is clinically important, as the presence of significant bony stenosis alters both the therapeutic decision-making and the expected outcomes of minimally invasive interventions. This condition imposes a significant personal and socioeconomic burden, ranking among the top chronic pain conditions for prevalence and years lived with disability [1, 2]. The natural history of cervical radicular pain is often favorable, with a substantial proportion of patients experiencing improvement with conservative management within the first several months post-onset [3–5]. Conservative strategies typically include rest, physical therapy, pharmacological agents (such as non-steroidal anti-inflammatory drugs, neuropathic pain medications, and muscle relaxants), and cervical immobilization [3, 6, 7]. However, a notable subset of patients—estimates suggest between 26 and 35%—exhibit persistent, severe symptoms that are refractory to exhaustive non-operative measures, necessitating escalation of treatment [3, 4]. For decades, the conventional surgical mainstay for refractory cases has been anterior cervical discectomy and fusion (ACDF), which offers reliable nerve root decompression and favorable outcomes [8–10]. Despite its efficacy, ACDF is associated with inherent risks, including dysphagia, hoarseness, adjacent segment disease, hardware-related complications, and the morbidity of an open surgical procedure [11, 12]. Furthermore, the necessity of spinal fusion in all cases has been questioned, driving the evolution of motion-preserving alternatives such as cervical disc arthroplasty and posterior cervical foraminotomy [8, 10]. Parallel to the refinement of these open techniques, the last 2 decades have witnessed a paradigm shift toward minimally invasive percutaneous interventions. This trend is fueled by the desire to achieve symptomatic relief while minimizing tissue trauma, reducing perioperative morbidity, facilitating rapid recovery, and enabling treatment in outpatient or day-surgery settings [13–15]. Among these percutaneous strategies, two distinct yet conceptually interlinked modalities have garnered significant clinical and research interest: percutaneous cervical nucleoplasty (PCN) and targeted radiofrequency (RF) procedures. PCN, predominantly utilizing low-temperature plasma radiofrequency (coblation) technology, is a decompressive technique. It aims to reduce intradiscal volume and pressure by ablating a portion of the nucleus pulposus, thereby indirectly relieving mechanical compression on the affected nerve root [13, 16, 17]. In contrast, targeted RF techniques, particularly pulsed radiofrequency (PRF) applied to the dorsal root ganglion (DRG), are primarily neuromodulatory. PRF delivers high-frequency electrical pulses near neuronal tissue without causing significant thermal destruction, aiming to modulate pain signal transmission and dampen neuropathic and inflammatory pain pathways [18–20]. This review synthesizes the contemporary evidence from the past 2 decades on the application, efficacy, safety, and evolving roles of low-temperature plasma nucleoplasty (PCN) and targeted radiofrequency therapies, chiefly PRF, in the management of cervical spondylotic radiculopathy. It will critically appraise the clinical outcomes of each modality independently, compare their effectiveness against each other and conventional surgery, explore emerging combination strategies, examine factors guiding patient selection, and outline the current safety profile. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Technical Background: Mechanisms and Procedures of PCN and Targeted RF A clear understanding of the distinct mechanisms of action and procedural techniques is essential for evaluating the clinical applications and outcomes of percutaneous cervical nucleoplasty (PCN) and targeted radiofrequency therapies. Percutaneous Cervical Nucleoplasty (PCN) and Coblation Technology PCN is a minimally invasive decompressive procedure designed for contained cervical disc herniations, where the outer annulus fibrosus remains intact. The most widely utilized technology is plasma-mediated ablation, known as coblation. This technology employs a bipolar radiofrequency current passed through a conductive medium (typically saline) at the tip of a specialized wand (e.g., SpineWand). This generates a precisely focused plasma field of highly ionized particles. These energized particles possess sufficient kinetic energies to break down molecular bonds within the nucleus pulposus, effectively dissolving or ablating the tissue at relatively low temperatures (typically 40–70 °C). The process results in the volumetric removal of nuclear material, thereby reducing intradiscal pressure [16, 17, 21]. Crucially, the low-temperature nature of coblation minimizes thermal damage to surrounding structures, including the annulus, endplate, and adjacent neural elements, a concern associated with earlier thermal techniques like laser discectomy [22, 23]. The procedure is typically performed under local anesthesia with fluoroscopic or computed tomography (CT) guidance. An anterolateral approach is most common, navigating between the trachea/esophagus medially and the carotid artery laterally to access the disc space [13, 17]. The wand is advanced into the nucleus, creating ablation channels, often accompanied by coagulation mode to thermally treat the channel walls. Beyond simple mechanical decompression, preclinical evidence suggests PCN may also exert a biochemical effect by reducing the activity of inflammatory mediators like phospholipase A2 within the degenerative disc, potentially contributing to pain relief [24]. Targeted Radiofrequency Procedures: Thermal vs. Pulsed Radiofrequency techniques applied in pain management can be broadly categorized into continuous (thermal) and pulsed modes. Continuous radiofrequency (CRF) or thermal radiofrequency generates a continuous current, leading to significant heat production (typically 60–90 °C) at the electrode tip. This creates a circumscribed thermal lesion, resulting in the neurodestruction of target nerves, such as the medial branches innervating cervical facet (zygapophysial) joints. Its efficacy in providing sustained relief for facet-mediated pain, including cervicogenic headache, is well documented when proper diagnostic blocks are performed [25–27]. However, its direct application to sensory nerve roots or the DRG carries a risk of deafferentation pain, numbness, or motor deficits [28]. Pulsed radiofrequency (PRF) was developed to provide neuromodulation without neurodestruction. PRF delivers short, high-voltage bursts of current (pulses) followed by long silent periods. This design allows heat to dissipate, keeping the average tissue temperature below 42°C, a threshold generally considered non-destructive [19, 20]. The precise mechanism of PRF's analgesic effect remains an active area of research but it is believed to involve complex neuromodulation. Proposed mechanisms include induction of long-term depression in synaptic transmission, modulation of synaptic plasticity via effects on neurotransmitters (e.g., glutamate, endogenous opioids), downregulation of pro-inflammatory cytokines (e.g., TNF-α, IL-6), deactivation of spinal microglia, and alteration of gene expression (e.g., c-Fos) in the dorsal horn of the spinal cord [19, 20, 29, 30]. For cervical radiculopathy, PRF is usually applied adjacent to or on the symptomatic cervical dorsal root ganglion (DRG) under fluoroscopic, CT, or increasingly, ultrasound guidance [18, 31, 32]. The goal is to modulate the hyperexcitable state of the DRG neurons involved in pain signaling from the inflamed or compressed nerve root. Clinical Evidence for Percutaneous Cervical Nucleoplasty (PCN) A substantial body of evidence, primarily from observational studies and a limited number of randomized controlled trials (RCTs), supports the clinical use of PCN for cervical radiculopathy due to contained disc herniation. Outcomes are frequently measured using pain scales like the Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS), functional indices such as the Neck Disability Index (NDI), and patient-reported satisfaction criteria like the MacNab scale. Short- and Mid-term Efficacy Numerous case series and retrospective studies have consistently reported significant pain reduction and functional improvement following PCN. Early studies demonstrated success rates (excellent/good outcomes according to the MacNab criteria) ranging from 77% to > 90% at short-term follow-up (weeks to months) [17, 21, 33]. A prospective case series of 126 patients by Li et al. found an 83.7% excellent/good rate at 1 year, with statistically significant VAS improvements at all follow-up points [17]. These findings were echoed in later studies, with Kim et al. reporting significant VAS score reductions from a preoperative mean of 7.50 to 3.20 at 3 months and 2.91 at a mean 15.4-month follow-up in patients with challenging foraminal disc herniations [34]. A systematic review and meta-analysis by Rybaczek et al. incorporating data from multiple studies on minimally invasive techniques confirmed a significant reduction in pain scores following cervical nucleoplasty [14]. Long-term Outcomes and Durability While long-term data are scarcer, several studies suggest that the benefits of PCN can be sustained. A retrospective cohort study by de Rooij et al. with a median follow-up of 41.5 months found that patients maintained a mean decrease of 2.8 points on the NRS for arm pain from baseline. At this long-term point, 67.8% of patients reported being fully recovered, and 93.3% remained satisfied with the treatment results [35]. Another long-term study by Li et al. focusing on patients with both neck pain and cervical vertigo found satisfactory clinical efficacy at 3-year follow-up, though some decline was noted by 6 years [36]. Importantly, the long-term reoperation rate for recurrent disc herniation in the study by de Rooij et al. was 21.4%, which the authors deemed acceptable for this minimally invasive option [35]. Zhang et al. compared cervical and lumbar coblation outcomes over 5 years, finding that the cervical group maintained a significantly higher efficacy rate (81.82%) and better MacNab scores than the lumbar group, highlighting the potentially favorable long-term profile of cervical nucleoplasty [37]. Application Beyond Typical Radiculopathy PCN has also been explored for atypical presentations of cervical disc disorders. Studies have reported its efficacy in alleviating cervical discogenic pain without frank radiculopathy [38], cervical discogenic upper back pain [39], cervical vertigo [36, 40], and even cervicogenic headache when related to disc pathology [41]. For instance, a retrospective study on cervical vertigo reported good to excellent results in 75.7% of patients at a minimum 1-year follow-up after PCN [40]. Another study found percutaneous plasma disc decompression (PPDD, synonymous with PCN) via a lower surgical approach was more effective than PRF alone for long-term remission of cervicogenic headache associated with cervical spondylotic radiculopathy [41]. Comparison with Conservative Care The evidence directly comparing PCN with structured conservative treatment is limited but suggestive. A 2010 RCT by Cesaroni and Nardi compared plasma disc decompression to conservative care (CC) over 1 year. The PDD group showed significantly greater reductions in VAS pain scores and greater improvement in NDI scores at all follow-up time points (6 weeks to 1 year). Notably, while PDD patients showed continued stable improvement, CC patients appeared to suffer a "relapse" with a decline in most measurements at the 1-year mark [42]. A more recent Cochrane review (de Rooij et al. 2025) identified one study in this comparison, concluding with low-certainty evidence that PCN may result in a large reduction in pain at short-term follow-up compared with conservative treatment, but found no clear difference in neck-related function or quality of life [43]. Clinical Evidence for Pulsed Radiofrequency (PRF) Targeting the Dorsal Root Ganglion Pulsed radiofrequency applied to the cervical dorsal root ganglion has emerged as a prominent neuromodulatory intervention for chronic cervical radicular pain, particularly in cases where inflammatory components are predominant or where decompressive surgery is not indicated or desired. Mechanistic Insights and Clinical Efficacy The rationale for DRG PRF lies in its ability to modulate pain signaling without causing neural damage. Clinical studies, including prospective and randomized trials, have generally supported its effectiveness. A meta-analysis of four studies by Kwak et al. concluded that PRF on the DRG significantly reduced VAS scores for cervical radicular pain at 2 weeks, 1, 3, and 6 months post-procedure [44]. A more recent prospective RCT by Chalermkitpanit et al. provided robust evidence. This double-blinded trial compared ultrasound-guided periradicular cervical nerve root PRF (followed by steroid/local anesthetic injection) to steroid/local anesthetic injection alone. At 3 months, 70% of the PRF group reported ≥ 50% pain reduction compared with only 23.8% in the steroid-only group. Patients in the PRF group had significantly lower pain scores and demonstrated significant improvement in the Neck Disability Index at 3 and 6 months. The duration of meaningful pain relief was also significantly longer in the PRF group (6.0 ± 4.1 months) compared with the steroid group (2.3 ± 2.1 months) [31]. This aligns with the understanding that while epidural steroid injections can provide potent anti-inflammatory relief, their effects are often transient, whereas PRF may induce longer lasting neuromodulatory changes [4, 45]. Comparison to Epidural Steroid Injections The comparative effectiveness of PRF versus transforaminal epidural steroid injections (TFESI) has been directly investigated. An RCT by Lee et al. compared PRF of the DRG to an additional TFESI in patients with persistent radicular pain (cervical and lumbar) after a first failed TFESI. The study found that both interventions led to significant reductions in VAS and disability scores over 12 weeks, with no statistically significant difference between the two groups at any time point. This suggests that PRF might be as effective as a repeat TFESI while potentially avoiding the risks associated with repeated steroid administration [46]. Another study focusing on cervical radicular pain refractory to repeated TFESIs found that subsequent PRF treatment under ultrasound guidance resulted in significant pain reduction and functional improvement at 1, 3, and 6 months, with 63.3% of patients achieving successful pain relief (≥ 50% reduction) at 6 months [32]. Application for Cervicogenic Headache PRF has also been applied to the C2 dorsal root ganglion or upper cervical nerves for the treatment of cervicogenic headache (CeH), a condition often linked to upper cervical spine pathology. A retrospective analysis by Lee et al. of C2 DRG PRF for CeH found that 40% of patients had ≥ 50% pain relief at 6 months, particularly among those with a definite positive response to a prior diagnostic C2 block [47]. CT-guided C2 DRG thermal radiofrequency ablation (a more destructive, continuous RF modality) has also been reported as efficacious [48]. A systematic review by Goyal et al. on interventions for CeH noted that while evidence is limited, PRF and RFA appeared to have favorable long-term outcomes, with pulsed therapy potentially offering a better safety profile [49]. However, a separate systematic review by Grandhi et al. concluded that the evidence for RFA and PRF in CeH was of very limited quality, underscoring the need for more rigorous studies [50]. Comparative Effectiveness: PCN vs. PRF vs. Conventional Surgery Direct comparisons between these minimally invasive techniques and the gold standard of surgery are crucial for defining their respective roles in clinical practice. The evidence base, while growing, remains characterized by a limited number of RCTs and studies with moderate to low certainty. PCN Versus Anterior Cervical Discectomy (ACD) The most direct comparison comes from an RCT by de Rooij et al., which randomized patients with single-level contained soft-disc herniation to either PCN or ACD. At the 3-month follow-up, intention-to-treat analysis revealed that the ACD group performed significantly better on the primary outcome of arm pain reduction. However, the authors debated the clinical relevance of this difference. By the 12-month follow-up, no significant differences were found between the groups on any outcome parameters, leading the authors to conclude that PCN could be a good longer-term alternative to ACD [11]. This finding is corroborated by other comparative studies. A clinical trial by Abrishamkar et al. found no significant difference in cervical pain reduction between discectomy and nucleoplasty groups over 6 months, though radicular pain relief was better in the discectomy group at 2 and 3 months [51]. The recent Cochrane review (2025) analyzed two studies comparing nucleoplasty to discectomy, finding low- to very-low-certainty evidence for little to no difference in neck pain, arm pain, neck-related function, recovery, or adverse events at short-term follow-up [43]. These collective findings suggest that while open discectomy may offer more rapid and potentially more complete initial relief, PCN can achieve comparable long-term outcomes in carefully selected patients, with the inherent advantages of minimal invasiveness. PCN Versus Pulsed Radiofrequency (PRF) Few studies have directly compared these two minimally invasive modalities. A prospective RCT by Halim et al. assigned 34 patients with contained cervical disc herniation to either PCN or PRF of the DRG. At 3 months, both groups showed significant and substantial improvement in mean VAS pain scores from baseline (PCN: 43.4-point improvement; PRF: 34.0-point improvement). However, there was no statistically significant superiority of one treatment over the other [52]. The Cochrane review identified this same study, noting very-low-certainty evidence that precluded firm conclusions about relative effects on pain, function, or recovery [43]. This equipoise suggests that the choice between PCN (a decompressive procedure) and PRF (a neuromodulatory procedure) may depend more on the perceived primary pathophysiology (mechanical compression vs. inflammatory/neuropathic irritation) and individual patient characteristics than on a clear hierarchy of efficacy. PRF Versus Surgery Direct comparisons of PRF to surgical decompression are lacking in the literature for cervical radiculopathy. PRF is generally considered an option for patients who are not surgical candidates, who wish to avoid surgery, or who have persistent pain after surgery. Its role is often positioned within a treatment algorithm after failed conservative care (including epidural injections) and before consideration of more invasive surgical options [4, 18]. Based on the comparative evidence discussed above and the complementary mechanisms of action, a proposed clinical decision-making algorithm for minimally invasive interventions in cervical spondylotic radiculopathy is presented in Fig. 1. Proposed clinical decision-making algorithm for minimally invasive interventions in cervical spondylotic radiculopathy. CSR cervical spondylotic radiculopathy, PCN percutaneous cervical nucleoplasty, PRF pulsed radiofrequency, DRG dorsal root ganglion, ACDF anterior cervical discectomy and fusion A structured overview of the key clinical studies evaluating PCN and PRF for cervical spondylotic radiculopathy, including their designs, outcomes, and comparative findings, is provided in Table 1. Table 1Summary of key clinical studies on PCN and PRF for cervical spondylotic radiculopathyAuthor/yearStudy designSample sizeInterventionComparatorPrimary outcomesFollow-up durationKey findings summarySuccess/excellent-good rateLevel of evidenceLi et al. (2008)Prospective case seriesN = 126PCN (coblation)None (single-arm)VAS (pain), MacNab criteria12 monthsSignificant VAS reduction from baseline at all follow-up time points post-procedure83.7% excellent/good (1 year)IVCesaroni and Nardi (2010)RCTN = 55 (PDD: 28; Conservative: 27)Plasma disc decompression (PDD/PCN)Conservative careVAS (pain), NDI12 monthsSignificantly greater VAS and NDI improvement in PDD group vs. conservative; conservative group showed relapse at 1 yearNot explicitly reported; PDD group mean VAS decreased from ~ 7.5 to ~ 3IIde Rooij et al. (2020)RCTN = 33 (PCN: 17; ACD: 16)PCNAnterior cervical discectomy (ACD)Arm pain NRS (primary)12 monthsACD significantly better at 3 months for arm pain; no significant difference between groups on any outcome at 12 months12-month outcomes comparable between groupsIIde Rooij et al. (2022)Retrospective cohort studyN = 56PCNNone (single-arm)NRS (arm pain), recovery rate, satisfactionMedian 41.5 months (long-term)Mean NRS decrease of 2.8 points for arm pain; 67.8% fully recovered; 93.3% satisfied; reoperation rate 21.4%67.8% recovery rate; 93.3% satisfactionIVKim et al. (2022)Case series/technical noteN = 20PCN (for foraminal disc herniation)None (single-arm)VAS (pain)Mean 15.4 monthsMean VAS decreased from 7.50 pre-op to 3.20 at 3 months and 2.91 at final follow-up (both p < 0.001)Not separately reportedIVZhang et al. (2025)Retrospective comparative studyCervical group (see original article for exact N)PCN (coblation nucleoplasty)Simultaneous lumbar coblation (comparative arm)MacNab criteria, VAS5 yearsCervical group maintained significantly higher 5-year efficacy rate (81.82%) and better MacNab scores compared to lumbar group81.82% (5 years)IVLee et al. (2016)RCTN = 40 (PRF: 20; TFESI: 20)DRG-PRFRepeat transforaminal epidural steroid injection (TFESI)VAS, ODI/NDI12 weeksBoth groups significantly improved; no significant between-group difference at any time point; PRF is an effective alternative to repeat TFESINo significant difference vs. TFESIIIKwak et al. (2018)Meta-analysis (4 studies)Pooled analysisDRG-PRFVarious comparators (including steroid injections)VAS6 monthsPRF significantly reduced VAS at 2 weeks, 1, 3, and 6 months post-procedureSignificant effect size (see original meta-analysis)I (meta-analysis)Lee et al. (2020)Retrospective case seriesN = 30Ultrasound-guided PRF (refractory chronic cervical radicular pain)None (single-arm)NRS, success rate (≥ 50% pain reduction)6 monthsSignificant NRS reduction (p < 0.001); 63.3% achieved successful pain relief at 6 months63.3% (6 months, ≥ 50% pain reduction)IVChalermkitpanit et al. (2023)RCT (double-blind)N = 41 (PRF + steroid: 20; Steroid-only: 21)Ultrasound-guided PRF + steroid/local anestheticSteroid/local anesthetic injection alone ≥ 50% pain reduction, NDI6 monthsAt 3 months, 70% in PRF group vs. 23.8% in control achieved ≥ 50% pain reduction (p = 0.003); significantly longer duration of relief in PRF group (6.0 vs. 2.3 months)70% (3 months, ≥ 50% pain reduction)IIHalim et al. (2017)RCTN = 34 (PCN: 17; PRF: 17)PCN vs. DRG-PRFEach other (head-to-head)VAS3 monthsBoth groups showed significant VAS reduction from baseline; no statistically significant superiority of either treatmentNo significant between-group differenceIIWang et al. (2025)Retrospective matched-cohort studyMatched sample (see original article)PCN + ultrasound-guided PRF (combined)PRF aloneNeck and arm VAS, NDIMinimum 1 yearCombined group showed significantly lower neck and arm VAS and lower NDI at final follow-up vs. PRF alone; excellent/good rate 84.62% vs. 76.92% (non-significant)84.62% (combined) vs. 76.92% (PRF alone)IIIYang et al. (2025)RCTN = 90 (Triple therapy: 45; Dual therapy: 45)Low-temperature plasma RF ablation + ozone + collagenase (triple therapy)Ablation + ozone alone (dual therapy)VAS, JOA score6 monthsTriple therapy group showed significantly better VAS and JOA scores; excellent rate 93.33% vs. 75.56% (p < 0.05)93.33% (triple) vs. 75.56% (dual)IIData are presented as described in the original studiesPCN percutaneous cervical nucleoplasty, PRF pulsed radiofrequency, DRG dorsal root ganglion, RCT randomized controlled trial, VAS visual analog scale, NRS numeric rating scale, NDI Neck Disability Index, ODI Oswestry Disability Index, TFESI transforaminal epidural steroid injection, PDD plasma disc decompression, ACD anterior cervical discectomy, JOA Japanese Orthopaedic Association, RF radiofrequency Summary of key clinical studies on PCN and PRF for cervical spondylotic radiculopathy Data are presented as described in the original studies PCN percutaneous cervical nucleoplasty, PRF pulsed radiofrequency, DRG dorsal root ganglion, RCT randomized controlled trial, VAS visual analog scale, NRS numeric rating scale, NDI Neck Disability Index, ODI Oswestry Disability Index, TFESI transforaminal epidural steroid injection, PDD plasma disc decompression, ACD anterior cervical discectomy, JOA Japanese Orthopaedic Association, RF radiofrequency Stepwise approach to procedure selection: Based on the evidence synthesized above, we propose the following stepwise approach for determining the appropriate minimally invasive intervention. (1) Confirm diagnosis and exclude contraindications: CSR diagnosis should be confirmed by clinical evaluation and MRI. Severe cervical central canal stenosis, bony foraminal stenosis, sequestrated disc fragments, myelopathy, and segmental instability must be excluded as they preclude PCN. (2) Assess predominant pathophysiology: When imaging reveals a soft, contained disc herniation with mechanical nerve root compression, PCN is the preferred decompressive option. When radicular pain is predominantly neuropathic or inflammatory in nature—particularly in patients who have experienced temporary relief from diagnostic nerve root blocks—PRF of the DRG is the preferred neuromodulatory option. (3) Consider combination therapy: In patients with evidence of both mechanical compression and significant neuroinflammatory pain, a combined approach (PCN + PRF) may be considered, supported by emerging evidence for superior outcomes compared to either modality alone (see Sect. "Emerging Strategies: Combination Therapies (PCN + PRF) and Augmented Techniques"). (4) Evaluate outcomes: Patients should be reassessed at regular intervals post-procedure. Those with unsatisfactory relief should be re-evaluated for repeat minimally invasive intervention or referral for open surgical options such as ACDF. This algorithmic approach is illustrated in Fig. 2. Emerging Strategies: Combination Therapies (PCN + PRF) and Augmented Techniques Recognizing the multifactorial nature of cervical radicular pain—involving both mechanical compression and neuroinflammatory irritation—has spurred interest in combining or augmenting minimally invasive techniques to target multiple pain generators simultaneously. Combination of PCN and PRF The synergistic potential of combining decompressive nucleoplasty with neuromodulatory PRF is a logical development. A retrospective matched-cohort study by Wang et al. compared the combination of PCN and ultrasound-guided PRF of the cervical nerve root to PRF alone. After propensity score matching, the combination (PCN + PRF) group demonstrated superior outcomes at the final follow-up (minimum 1 year), with significantly lower neck and arm pain VAS scores, lower NDI scores, and higher clinical assessment scale scores compared with the PRF-alone group. The excellent/good rate was 84.62% for the combination versus 76.92% for PRF alone, though this difference was not statistically significant. The study concluded that the combined strategy was effective and safe [53]. This approach theoretically addresses both the discal source of compression and the hyperexcitable state of the affected nerve root/DRG, potentially leading to more comprehensive and durable relief. Augmentation of PCN with Adjunct Therapies Researchers are also exploring the enhancement of PCN by combining it with other intradiscal therapies. A randomized controlled trial by Yang et al. investigated a triple therapy consisting of low-temperature plasma radiofrequency ablation combined with intradiscal ozone injection and collagenase compared with ablation plus ozone alone (dual therapy) for cervical disc herniation. At the 6-month follow-up, the triple therapy group showed significantly better VAS and Japanese Orthopaedic Association (JOA) scores and a higher excellent rate (93.33% vs. 75.56%). The addition of collagenase, an enzyme that degrades the nucleus pulposus, appeared to enhance long-term pain relief and functional recovery without increasing safety risks [18]. Another earlier study reported promising results for radiofrequency combined with low-dose intradiscal collagenase injection via an anterior approach [54]. Intradiscal ozone injection alone has also been systematically reviewed as an effective nucleolysis technique for cervical disc herniation [55]. These augmented strategies aim to achieve greater disc decompression or additional biochemical effects beyond those of standard coblation. Technical Refinements Emerging technical approaches include ultrasound guidance for needle placement in procedures like percutaneous laser discectomy, as reported in a feasibility study by Hu et al., which may increase precision and safety by visualizing critical vascular structures [56]. Furthermore, targeting the sinuvertebral nerve at the herniation edge via CT-guided radiofrequency ablation has been explored for discogenic neck pain, with significant pain reduction reported in a retrospective study [57]. Similarly, coblation annuloplasty, targeting nerve fibers within the degenerative annulus, has shown efficacy in treating cervical discogenic pain without radiculopathy [38]. Patient Selection, Predictive Factors, and the Role of Imaging The success of minimally invasive interventions like PCN and PRF is highly dependent on appropriate patient selection. Identifying predictive factors for positive outcomes is therefore a critical area of research. Key patient selection criteria: Consensus from multiple studies indicates that the ideal candidate for PCN is a patient with persistent cervical radicular pain due to a soft, contained disc herniation (protrusion or subligamentous extrusion) that has failed an adequate course of conservative management (typically ≥ 6 weeks) [13, 17, 58, 59]. The presence of a intact outer annulus is considered crucial. Contraindications for PCN must be carefully reviewed on pre-procedural imaging. Absolute or relative contraindications include (1) sequestrated or migrated disc fragments that are no longer contained by the annulus or posterior longitudinal ligament; (2) severe cervical central canal stenosis or significant bony foraminal stenosis with calcified osteophytes; (3) clinical and radiological evidence of cervical myelopathy; (4) segmental instability (e.g., translation > 3 mm on dynamic radiographs); (5) calcified hard disc herniations that cannot be effectively ablated by plasma energy; (6) active local or systemic infection; and (7) suspected tumor or vertebral fracture. For PRF of the DRG, contraindications also include uncorrected coagulopathy and local infection at the puncture site. Notably, Kim et al. (2018) identified concurrent cervical central canal stenosis as an independent negative predictor of successful PCN outcome, underscoring the need for stringent imaging review before proceeding with any percutaneous intervention [13, 16, 60]. For PRF, patients with predominant neuropathic or inflammatory radicular pain components, including those who have had temporary relief from diagnostic or therapeutic nerve blocks, are considered suitable candidates [4, 31, 47]. Predictive factors for outcome: Several studies have attempted to identify factors that predict a successful outcome following PCN. A retrospective analysis by Kim et al. identified that shorter pain duration, absence of concurrent cervical central canal stenosis, unilateral radiculopathy (as opposed to axial neck pain alone), and the use of a curved-tip needle technique were independent positive predictors of success. Conversely, longer pain duration and the presence of spinal stenosis were negative predictors [60]. The importance of patient selection is underscored by a study by Halim et al., which found that patients selected under more stringent "ideal criteria" (e.g., single-level contained herniation) reported higher treatment satisfaction, better physical functioning scores, and a greater reduction in medication use postoperatively compared with a less strictly selected cohort [61]. A significant contribution to predicting outcomes, particularly recurrence, comes from Xie and Wang [62]. Their study developed and validated a high-precision nomogram prediction model for the risk of recurrence 1 year after surgery (including CT-guided RF ablation or low-temperature plasma RF) for cervical spondylotic radiculopathy. The model identified symptom duration, the presence of numbness, and the preoperative Numeric Rating Scale (NRS) pain score as significant predictors of recurrence. This tool can aid clinicians in the early identification of high-risk patients, allowing for more intensive follow-up or consideration of more definitive initial treatments [62]. Role of Advanced Imaging While MRI remains the cornerstone for anatomical diagnosis, its findings do not always correlate perfectly with symptoms or outcomes. A study by Yang et al. found that the type and extent of cervical disc herniation (bulge vs. herniation) on preoperative MRI did not correlate with the severity of symptoms at presentation or with clinical outcomes 2 years after anterior discectomy [63]. This reinforces the principle that treatment decisions must be based on a combination of imaging and clinical correlation. Beyond structural MRI, advanced imaging techniques are being explored for prognostic value. Diffusion tensor imaging (DTI), as investigated by Fan et al., found that fractional anisotropy (FA) values of cervical nerve roots before and after PCN were strongly negatively correlated with Neck Disability Index scores, suggesting DTI could be a potential predictor of functional prognosis [64]. Digital infrared thermographic imaging (DITI) has also been studied, with Kim et al. reporting that preoperative DITI findings could be useful for predicting pain reduction after PCN, although changes in thermal difference did not directly correlate with changes in pain scores [65]. Safety Profile and Complications A principal advantage of both PCN and PRF is their favorable safety profile compared with open cervical surgery. The reported complication rates are generally low, with most adverse events being minor and transient. Safety of Percutaneous Cervical Nucleoplasty (PCN) Major complications from PCN are rare. Systematic reviews and large case series consistently report a low incidence of serious adverse events [14, 59, 66]. The meta-analysis by Eichen et al. reported a total complication rate of 1.5% for nucleoplasty (cervical and lumbar), with the cervical-specific rate at 0.8% [66]. The most commonly reported device-related complication is breakage of the probe tip within the disc, which has been described in isolated case reports and typically remains asymptomatic with no long-term sequelae [17, 22]. Infectious discitis is a potential risk with any percutaneous disc procedure but appears uncommon with strict aseptic technique [22]. Other rare complications could include injury to anterior neck structures (vessels, trachea, esophagus, or recurrent laryngeal nerve), though these are mitigated by proper imaging guidance and technique [12, 13]. No procedure-related neurological complications such as nerve root injury or spinal cord damage were reported in the major reviewed studies [17, 34, 35, 52]. A systematic review from 2025 identifieded discitis and device-related issues as the most frequently reported adverse events for minimally invasive percutaneous techniques, with an overall reoperation rate of 3.4% [14]. Safety of Pulsed Radiofrequency (PRF) PRF is celebrated for its excellent safety profile, attributable to its non- or minimally neurodestructive nature. Unlike continuous thermal RF, PRF carries a very low risk of causing deafferentation pain, neuritis, or motor deficits [28, 45, 67]. The most common adverse effects are typically mild and transient, such as post-procedural soreness at the needle insertion site or a temporary increase in radicular pain. Studies specifically investigating PRF for cervical radiculopathy, including RCTs, have reported no serious complications [31, 32, 46, 52]. The posterior approach for cervical nerve root block and PRF has also been described as safe, with no serious adverse effects observed in a retrospective study [68]. Comparative Safety with Surgery When contrasted with anterior cervical discectomy and fusion, the safety advantage of percutaneous techniques is evident. ACDF, while highly effective, carries risks of dysphagia, hoarseness, hematoma requiring reoperation (approximately 0.4% incidence), esophageal injury, dural tear, graft/hardware failure, and adjacent segment disease [12, 69]. Posterior endoscopic approaches, while less invasive than open fusion, have their own complication profiles, including transient dysesthesia, dural tears, and nerve root injury [12]. The minimally invasive nature of PCN and PRF, often performed under local anesthesia in an outpatient setting, avoids many of these systemic and access-related risks, leading to faster recovery and shorter or no hospitalization [13, 15, 52]. Conclusion and Future Perspectives The evolution of treatment for cervical spondylotic radiculopathy has been markedly influenced by the development and refinement of minimally invasive percutaneous techniques over the past 2 decades. Low-temperature plasma nucleoplasty (PCN) and pulsed radiofrequency (PRF) neuromodulation of the dorsal root ganglion represent two distinct yet complementary pillars in this armamentarium. Current evidence, synthesized from numerous observational studies and a growing number of randomized controlled trials, supports their roles as effective and safe treatment options for patients with persistent radicular pain who have not responded adequately to conservative management. PCN offers a minimally invasive decompressive solution for contained soft disc herniations. Evidence indicates it can provide significant and sustained pain relief and functional improvement, with long-term outcomes that may approach those of anterior cervical discectomy in carefully selected patients while offering the benefits of reduced morbidity and faster recovery [11, 35, 66]. PRF, on the other hand, provides a neuromodulatory intervention that is particularly suited for addressing the neuropathic and inflammatory components of radicular pain. High-quality RCTs demonstrate their superiority over steroid injections alone in providing longer-lasting pain relief and functional recovery for chronic cervical radiculopathy [31, 46]. Direct comparisons between PCN and PRF show equipoise in efficacy, suggesting the choice may be guided by the predominant pathoanatomical and pathophysiological features in each case [52]. The frontier of this field is moving toward personalized and combinatorial strategies. The synergistic combination of PCN and PRF appears promising for targeting both the mechanical and neuroinflammatory axes of pain [53]. Furthermore, augmenting core techniques with adjuncts such as intradiscal collagenase or ozone may enhance outcomes [18, 55]. Critical to advancing these therapies is the refinement of patient selection. Predictive models incorporating clinical factors such as symptom duration, the presence of numbness, and pain intensity are emerging tools that can help identify patients most likely to benefit or those at risk for recurrence [60, 62]. Despite the encouraging data, the evidence base is often graded as low to moderate certainty because of limitations in study design, sample sizes, and heterogeneity [43, 59]. Recently, a 2025 Cochrane review on nucleoplasty for cervical radicular pain concluded that current evidence is of low to very low certainty and emphasized the need for sufficiently powered, well-designed randomized controlled trials [43]. Our synthesis aligns with this assessment, and the treatment recommendations proposed herein should be regarded as conditional pending higher-quality evidence. There is a clear and pressing need for more large-scale, multicenter, rigorously designed randomized controlled trials. Future research should directly compare these minimally invasive modalities against each other and against standard surgical treatments with longer follow-up periods. Further investigation into the optimal technical parameters (e.g., PRF pulse characteristics, coblation energy settings), the integration of advanced imaging for prognosis, and the biological mechanisms underlying treatment effects will also be valuable. In conclusion, percutaneous cervical nucleoplasty and targeted pulsed radiofrequency have secured a definitive place in the modern, stepped-care approach to cervical spondylotic radiculopathy. They offer effective alternatives between failed conservative care and open surgical intervention, aligning with the broader trend in spinal care toward treatments that maximize efficacy while minimizing invasiveness. As evidence continues to accumulate and techniques evolve, their role is poised to expand, offering hope for improved outcomes and quality of life for patients suffering from this prevalent and painful condition. Design considerations for future trials: To address the current evidence gaps, we recommend that future randomized controlled trials incorporate the following design elements. First, a mixed-methods approach that combines quantitative outcomes with qualitative assessments of patient experience would provide a more comprehensive understanding of the treatment's impact. Second, trials should employ a three-arm parallel design comparing (1) PCN alone, (2) PRF alone, and (3) combined PCN + PRF, with a possible fourth arm of sham control or continued conservative care. Randomization should be stratified by symptom duration (< 6 months vs. ≥ 6 months) and presence of neuropathic pain features, given their established predictive value. Blinding can be achieved through a double-dummy design, in which all patients receive both a percutaneous cervical approach (real or sham) and RF electrode placement (real or sham, with an inactive generator). Third, outcome assessment should extend beyond traditional pain scores (VAS/NRS) and MacNab criteria to include validated measures of physical function (Neck Disability Index), health-related quality of life (SF-36 or EQ-5D), and emotional response to pain (Pain Catastrophizing Scale, Hospital Anxiety and Depression Scale). Follow-up should extend for at least 24 months to capture long-term durability and reoperation rates. Only through such rigorously designed trials can the comparative effectiveness of these minimally invasive modalities be definitively established. Acknowledgements We thank the participants of the study. Author Contributions Conception/design (Keyue Xie); drafting or revising (Jiajia Deng, Chenxuan Xiao and Keyue Xie); final approval (Keyue Xie). We agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved by all authors. Funding This study was supported by the National Natural Science Foundation of China (82171216), Natural Science Foundation of Zhejiang Province of China (LTGC23H090002), Science and Technology Project of Jiaxing City (2023AY31025, 2023AD31048), Demonstration Special Project for Public Hospital Reform and High-Quality Development(2026-GZL-A09), Zhejiang Multidisciplinary Innovation Team of Traditional Chinese Medicine for Diagnosis and Treatment of Elderly Headache and Vertigo (2022–19), Zhejiang Clinovation Pride-Herpes zoster neuralgia(CXTD202502014), Student Research Training Program of Jiaxing University (grant no. 8517241009), and Zhejiang Provincial Clinical Key Specialties-Anesthesiology (2023-ZJZK-001). The Rapid Service Fee was funded by the authors. Data Availability Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Declarations Conflict of Interest Jiajia Deng, Chenxuan Xiao and Keyue Xie declare that they have no conflict of interest. Ethical Approval This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. References Associated Data Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.